Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Alpha+omega Semiconductor

Start price
Target price
Perf. (%)
€45.31
05.04.22
€55.00
05.04.23
-7.37%
28.04.22

Could be worthwhile Investment >10% per year
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€3.03
23.04.21
€3.50
23.04.22
-20.62%
24.04.22

Could be worthwhile Investment >10% per year
buy
ImmunityBio Inc.

Start price
Target price
Perf. (%)
€14.64
19.04.21
-
19.04.22
-68.10%
20.04.22

Could be very worthwhile Investment >20% year
buy
Energous Corp.

Start price
Target price
Perf. (%)
€2.70
18.04.21
€3.50
18.04.22
-64.01%
19.04.22

Could be worthwhile Investment >10% per year
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.64
06.04.22
€1.00
06.04.23
-22.00%
18.04.22

Probably not worthwhile Investment
Decining EBIT margin than peer group
overvalued
Very low/no dividend yield expected
buy
Veru Inc

Start price
Target price
Perf. (%)
€12.02
11.04.22
€55.00
11.04.23
-2.33%
18.04.22

EBIT growth > 30% per year expected
Strong uniques
Very differentiated customer and product portfolio
ROE lower than 10% per year
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.64
06.04.22
€0.000
06.04.23
-22.00%
18.04.22

Could be worthwhile Investment >10% per year
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Veru Inc

Start price
Target price
Perf. (%)
€9.33
13.04.22
€3.20
13.04.23
25.81%
18.04.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€21.05
07.04.22
-
07.04.23
-7.36%
18.04.22

Risky Investment
buy
Overstock.com

Start price
Target price
Perf. (%)
€45.87
10.02.22
-
10.02.23
-22.69%
17.04.22

Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€6.45
27.11.21
€3.30
27.11.22
-52.69%
12.04.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€145.98
11.11.21
€75.00
11.11.22
-63.74%
11.04.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
buy
Aqua Metals Inc

Start price
Target price
Perf. (%)
€3.42
03.04.21
€4.50
03.04.22
-57.15%
04.04.22

Could be worthwhile Investment >10% per year
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€28.50
28.03.22
-
28.03.23
-8.07%
02.04.22

Risky Investment
Vertex Energy Inc.

Start price
Target price
Perf. (%)
€8.05
29.03.22
-
29.03.23
24.22%
01.04.22

Probably not worthwhile Investment
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€28.44
28.03.21
€46.00
28.03.22
-9.76%
29.03.22

buy
Formfactor Inc.

Start price
Target price
Perf. (%)
€37.20
24.03.21
€40.00
24.03.22
7.53%
25.03.22

Could be worthwhile Investment >10% per year
buy
Applied Optoelectronics Inc.

Start price
Target price
Perf. (%)
€7.17
21.03.21
-
21.03.22
-57.88%
22.03.22

Risky Investment
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.015
20.02.22
€7.50
20.03.22
61900.00%
21.03.22

Could be worthwhile Investment >10% per year
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€81.03
15.03.22
-
15.03.23
-14.84%
20.03.22

Could be worthwhile Investment >10% per year
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€20.25
06.03.22
-
06.03.23
13.33%
17.03.22

Risky Investment
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€20.53
14.03.22
€14.00
14.03.23
3.70%
16.03.22

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
buy
Cadiz Inc.

Start price
Target price
Perf. (%)
€5.35
01.11.21
-
01.11.22
-67.48%
16.03.22

Could be worthwhile Investment >10% per year
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€36.28
15.03.21
-
15.03.22
-43.36%
16.03.22

Lower EBIT Margin than peer group
Probably not worthwhile Investment
Revenue decline/stagnation expected
High valuation
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€30.25
13.10.21
€34.00
30.07.22
-32.13%
14.03.22

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating